Here’s Why Progyny (PGNY) Was Under Pressure in Q3
Polen Capital, an investment management company, released its “Polen U.S. Small Company Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Progyny Inc. (PGNY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Invenomic Capital Management Ali Motamed | 1,760,706 | $29,509,433 | 1.62% | |
| 2. | Owls Nest Partners Philip Timon | 1,523,147 | $25,527,944 | -19% | 6.51% |
| 3. | Farallon Capital Thomas Steyer | 931,307 | $15,608,705 | -29% | 0.07% |
| 4. | Point72 Asset Management Steve Cohen | 789,418 | $13,230,640 | +228% | 0.03% |
| 5. | Millennium Management Israel Englander | 563,535 | $9,444,847 | +6% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.00 | 76,923 | Director | 76,923 | 2019-10-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.00 | 9,030 | Officer | 362,583 | 2024-07-16 | Filing | |
| $28.39 | 1,462 | Director | 10,098 | 2024-06-28 | Filing | |
| $31.95 | 4,515 | Officer | 380,038 | 2024-05-01 | Filing | |
| $37.52 | 1,000 | Officer, Director | 83,631 | 2024-04-01 | Filing | |
| $37.60 | 1,880 | Officer | 384,553 | 2024-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,111,570 | $450,308,171 | 0.01% | |
| 2. | 8,270,153 | $307,484,289 | 0% | |
| 3. | 6,597,672 | $245,301,445 | 3.95% | |
| 4. | 3,492,360 | $129,845,940 | 0.11% | |
| 5. | 3,198,757 | $118,929,782 | 0.01% |
News See All
Progyny, Inc. (NASDAQ:PGNY) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Progyny, Inc. Third Quarter Earnings Conference Call. At this time all participants have been placed on listen-only mode.
Here’s What Affected Progyny's (PGNY) Share Price in Q2
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Progyny, Inc. (NASDAQ:PGNY) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, everyone and welcome the Progeny Inc. Second Quarter 2024 Earnings Conference Call.
Progyny (PGNY) Slipped Due to Lower-Than-Expected Benefit Utilization
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” second-quarter 2024 investor letter. A copy of the same can be downloaded here.
Progyny, Inc. (NASDAQ:PGNY) Q1 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the Progyny, Inc. First Quarter 2024 Earnings Call.
Jim Cramer's 10 Favorite Healthcare Stock Picks in 2024
In this article, we will take a detailed look at Jim Cramer’s 10 Favorite Healthcare Stock Picks in 2024. For a quick overview of such stocks, read our article Jim Cramer’s 5 Favorite Healthcare...
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks...
Progyny, Inc. (NASDAQ:PGNY) Q4 2023 Earnings Call Transcript
Progyny, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $0.11. Progyny, Inc.
16 Best Mid-Cap Growth Stocks To Buy Now
Investors are hopeful that small- and mid-cap stocks will experience a broader rally this year after getting hammered for most part of the previous year as all eyes remain focused on the Magnificent Seven...
Billionaire Hedge Funds
